Jugleys A. Seijas-Acosta

Jugleys A. Seijas-Acosta

Auto-generated profile, based on publicly available information

Jugleys A. Seijas-Acosta

Department of Imaging, Clínica Alemana de Santiago, Santiago de Chile

Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 April 2026 in Radioprotection
Verified
Journal Article
Open access
PDF file
ADAdlin López Díaz
Adlin López Díaz
DGDagoberto E. González-López
Dagoberto E. González-López
JSJugleys A. Seijas-Acosta
Jugleys A. Seijas-Acosta
SRSergio Ramos-Avasola
Sergio Ramos-Avasola
JGJaime J. Gordon
Jaime J. Gordon
JDJorge L. Delgado-Morales
Jorge L. Delgado-Morales
Interventional cardiology procedures, particularly coronary angiography (CA) and percutaneous coronary intervention (PCI), are among the most radiation-intensive medical imaging techniques. Accurate estimation of patient radiation dose is essential for risk assessment, dose optimization, and the development of diagnostic reference levels. This scoping review critically analyzes the current literature on dose conversion factors based on kerma-area product (KAP) for estimating effective (E) and organ-specific (HT) doses in adult patients undergoing CA and PCI. A total of 14 studies meeting defined eligibility criteria were included, encompassing methodologies such as Monte Carlo simulations (e.g., PCXMC, Geant4), physical phantoms, and clinical measurements. Reported E/KAP factors varied from 0.14 to 0.33 mSv/Gy·cm², with PCI generally yielding higher values. HT/KAP values were notably highest for lungs and varied based on sex, anatomy, and procedural parameters. Technical factors such as X-ray filtration also significantly influenced dose estimation. The findings highlight substantial methodological heterogeneity and emphasize the need to standardize conversion factor recommendations across settings. Future efforts should focus on integrating personalized dosimetry, artificial intelligence tools, and real-time dose monitoring to enhance radiological safety and ensure consistent practice in interventional cardiology.